Duchenne Muscular Dystrophy Treatment Market – Top Key Players and Industry Outlook
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive degeneration of the muscles and weakness in them. It is a rare muscle disease, which largely affects men.
Read Report Overview - https://www.transparencymarketresearch.com/duchenne-muscular-dystrophy-treatment-market.html
Duchenne muscular dystrophy (DMD) therapeutics help treat this genetic disorder caused due to absence of dystrophin, a protein in the human body. Symptoms of the disease include weakness in the muscles of the hips, the thighs, the pelvic area, and the shoulders. Later, weakness is observed in the muscles of the arms, the legs, and the trunk. Various therapies and drugs to control DMD are available, which include mutation suppression, exon skipping, and steroid therapy.
DMD is caused by changes (mutations) of the DMD gene on the X chromosome
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75539
Key Drivers and Restraints of Global Duchenne Muscular Dystrophy Treatment Market
Increase in the number of patients with Duchenne muscular dystrophy is expected to propel the global Duchenne muscular dystrophy treatment market during the forecast period. According to the National Organization for Rare Disorders, one in 3,500 male babies born worldwide are affected with Duchenne muscular dystrophy. Overall, muscular dystrophies affect 250,000 individuals in the U.S.
Increase in the number of clinical trials for testing the future treatment for Duchenne muscular dystrophy and wide product pipeline are likely to drive the global market for Duchenne muscular dystrophy treatment during the forecast period. Ataluren, casimersen, golodirsen, suvodirsen, and viltolarsen are five drug molecules undergoing Phase-3 clinical trial for their use in the treatment of Duchenne muscular dystrophy. EXONDYS 51 has been recently approved for treatment of the disease.
Low rate of treatment caused by delayed diagnosis of the disease is restraining global Duchenne muscular dystrophy treatment market
Request for Analysis of COVID-19 Impact on Duchenne Muscular Dystrophy Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75539
Exon Skipping Segment to Witness Significant Growth
Based on therapeutics, the global Duchenne muscular dystrophy treatment market can be segmented into mutation suppression, exon skipping, and steroid therapy
The exon skipping segment accounted for the maximum share of the global Duchenne muscular dystrophy treatment market in 2018. The segment is expected to continue its dominance in the next few years, as a majority of exon skipping drugs are undergoing Phase-3 clinical trials. Only one drug approved for Duchenne muscular dystrophy i.e. Exondy 51 falls under the exon skipping therapeutics.
Hospital Pharmacies Segment to Witness Significant Growth
In terms of distribution channel, the global Duchenne muscular dystrophy treatment market can be divided into hospital pharmacies, retail pharmacies, and online sales
The hospital pharmacies segment generated the maximum revenues in 2018 and it is anticipated to witness significant growth during the forecast period. This can be attributed to growing number of patients with Duchenne muscular dystrophy being hospitalized. Hence, drugs for Duchenne muscular dystrophy are being sold on a large scale through hospital pharmacies.
North America to Dominate Global Duchenne Muscular Dystrophy Treatment Market
In terms of region, the global Duchenne muscular dystrophy treatment market can be categorized into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America dominated the global Duchenne muscular dystrophy treatment market in 2018 and it is expected to maintain its leading position during the forecast period. The dominance of the region can be attributed to increasing research and development activities by major market players, expansion of product offerings by these players, and rise in the demand for early diagnosis in the region.
The market in Asia Pacific is projected to register the maximum growth rate during the forecast period, owing to increase in the adoption of new products and rise in the incidence of Duchenne muscular dystrophy in the region
Pre Book Duchenne Muscular Dystrophy Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=75539<ype=S
Key Manufacturers Operating in Global Market
The global Duchenne muscular dystrophy treatment market was highly fragmented in 2018. Key manufacturers operating in the global market are:
Sarepta Therapeutics, Inc.
NS Pharma, Inc.
Wave Life Sciences
Daiichi Sankyo Company
More Trending Reports by Transparency Market Research –
Heart Pumps Market: https://www.biospace.com/article/heart-pumps-market-simplistic-and-effective-centrifugal-flow-pumps-to-witness-high-demand/
Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Duchenne Muscular Dystrophy Treatment Market – Top Key Players and Industry Outlook here
News-ID: 2173984 • Views: 387
More Releases from Transparency Market Research
Market Intelligence Report on Calcite Market, 2018-2028
Sales of calcite have witnessed utter proliferation in recent time, in line with the growing demand from paper and pulp sector wherein calcite is highly adopted as a coating and filler material. According to Transparency Market Research analysis, global calcite market is anticipated to register 4.7% CAGR during the study period 2018–2028. The TMR report opines that demand for calcite is highly driven by its significant properties that are paving way
Pearlescent Pigments Market Intelligence Report Offers Growth Prospects
The demand within the global pearlescent pigment market is slated to rise as new creative avenues emerge in the art and craft industry. Several artists have increased the consumption of pearlescent pigments, mainly due to the aesthetic value of these pigments in art forms. The use of these pigments can majorly be attributed to the gloss and shine imparted by these pigments to the design or craft. These pigments exhibit
Aragonite Market to Witness Steady Growth During the Forecast Period 2018-2026
Global Aragonite Market: Overview Aragonite is a carbonate mineral having an orthorhombic crystal system, and very closely resembles calcite. It is considered as the purest form of calcium carbonate. The mineral has garnered wide popularity as gemstone in various parts of the world and has promising healing properties with energy enhancing powers. Aragonite contains traces of magnesium and sand inclusion but rich in calcium carbonate, and is alkaline in nature. It
OEM Insulation Market Growth, Trends and Value Chain 2019-2027 by TMR
OEM Insulation Market – Overview OEM means Original Equipment Manufacturer that indicates to a company that produces a part or a subsystem of a product that is being used by another organization. Thermal insulation or simply insulation allows the product to cut down the heat gain or loss at the minimum by creating a barrier between the surfaces at the varying temperatures. There are wide range of applications and end-use verticals
More Releases for Duchenne
Global Duchenne Muscular Dystrophy Market Research Report 2015-2025
About the Global Duchenne Muscular Dystrophy Market Research Report 2015-2025: Global Global Duchenne Muscular Dystrophy Market Research Report 2015-2025 2020 Research Report is divided into various key segments like device type, material, applications, and end users. The report is thoroughly analyzed and studied by the researchers to offer deep insights on each of these segments with statistics. This information is beneficial for the manufacturers in the industry to plan their policies
Global Duchenne Muscular Dystrophy Therapeutics Market Productions, Statistics 2 …
Qyresearchreports include new market research report "Global Duchenne Muscular Dystrophy Therapeutics Market Size, Status and Forecast 2022" to its huge collection of research reports. The general market for Duchenne Muscular Dystrophy Therapeutics has been analysed on various points of view that are practically present in the scenario, and have affected the market situation to the large extent. The report also presents exceptional experience and data identified with global Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Duchenne Muscular Dystrophy - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H2 2017, provides an overview of the Duchenne Muscular Dystrophy (Genetic Disorders) pipeline landscape. Duchenne muscular dystrophy is a condition which causes muscle weakness. DMD is an X-linked disorder.
Duchenne Muscular Dystrophy (DMD) Treatment Market - Global Industry Insights, T …
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. DMD is caused due to alteration in gene sequence coding for dystrophin proterin, which is present the muscle. It is a rare muscle disease which majorly affects males. The symptoms includes intellectual disability, muscle weakness and, difficulty in walking and breathing. Congestive heart failure, mental impairment, pneumonia or respiratory failure are some of the
Duchenne Muscular Dystrophy - Pipeline Review, H2 Pharmaceutical Research Report …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Duchenne Muscular Dystrophy - Pipeline Review, H2 2017”. Duchenne muscular dystrophy is a condition which causes muscle weakness. DMD is an X-linked disorder. The gene for DMD is present on the X chromosome. Request For Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1305512 It codes for a protein named dystrophin. Dystrophin is essential for providing structural support inside muscle cells.
Duchenne Muscular Dystrophy - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Duchenne Muscular Dystrophy - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H1 2017, provides an overview of the Duchenne Muscular Dystrophy (Genetic Disorders) pipeline landscape. Duchenne muscular dystrophy is a condition which causes muscle weakness. DMD is an X-linked disorder.